Increase/Decrease in Cash (Quarterly)

Increase/Decrease in Cash: The total change in cash for the company over the given period.

AVANOS MEDICAL, INC. (AVNS) had Increase/Decrease in Cash of $-1.50M for the most recently reported fiscal quarter, ending 2022-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2022-09-30

Income Statement Financials
Revenue	$202.10M
Net Income	$15.70M
Cost of Goods Sold	$92.00M
Gross Profit	$110.10M
Operating Expenses	$183.40M
Operating Income	$18.70M
Non-Operating Income/Expense	$-2.70M
Pre-Tax Income	$16.00M
Normalized Pre-Tax Income	$16.00M
Income after Taxes	$15.70M
Income from Continuous Operations	$15.70M
Consolidated Net Income/Loss	$15.70M
Normalized Income after Taxes	$15.70M
EBIT	$18.70M
EBITDA	$30.30M
Weighted-Average Shares Outstanding (Basic)	46.60M
Weighted-Average Shares Outstanding (Diluted)	47.00M
Earnings per Share (EPS) (Basic)	$0.34
Earnings per Share (EPS) (Diluted)	$0.33
Balance Sheet Financials
Current Assets	$470.00M
Property, Plant, and Equipment	$163.40M
Long-Term Assets	$1.31B
Total Assets	$1.78B
Current Liabilities	$162.30M
Long-Term Debt	$247.80M
Long-Term Liabilities	$349.40M
Total Liabilities	$511.70M
Common Equity	$1.26B
Tangible Shareholders Equity	$181.20M
Shareholders Equity	$1.26B
Common Shares Outstanding	46.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$57.20M
Cash Flow from Investing Activities	$-130.50M
Cash Flow from Financial Activities	$78.60M
Beginning Cash	$118.50M
End Cash	$117.00M
Increase/Decrease in Cash	$-1.50M
Stock-Based Compensation	$11.90M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.20
Gross Margin	54.48%
Operating Margin	9.25%
EBIT Margin	9.25%
EBITDA Margin	--
Pre-Tax Profit Margin	7.92%
Profit Margin	7.77%
Free Cash Flow	$42.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.11
Inventory Turnover	0.48
Receiveable Turnover	1.38
Days Sales in Receivables	65.11
Return on Equity	1.24%
Return on Tangible Equity	8.66%
Return on Assets	0.88%
Return on Investments	1.04%
Book Value Per Share	$27.17
Free Cash Flow per Share	$0.91
Operating Cash Flow per Share	$1.22

Data from Zacks Investment Research, Inc.